The $80 million facility officially opened its doors Thursday, though patients started seeing providers there earlier this month.

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than ...

Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults.

The hunt for better treatments led researchers to reimagine targeted therapies. By 2022 they had developed one that linked Herceptin to another cancer-killing drug.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

A new report reveals that gastrointestinal cancer rates are rising in young adults, with "Western diet" and lifestyle factors ...

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers, according to research ...

A personal trainer who followed a clean diet was diagnosed with colon cancer after her rectal bleeding and bloating were ...